Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
Bartosz Hudzik, Editorial Consultant at JACC Case Reports, shared on LinkedIn:
”Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
In CV medicine, we often think of coronary artery disease as either acute (requiring urgent evascularization) or chronic (managed primarily with GDMT).
But there’s a critical group in between that doesn’t fit neatly into either category: subacute coronary occlusions (SCOs).
These lesions present unique diagnostic and therapeutic challenges.
Unlike acute coronary syndromes, they may not demand immediate intervention-but unlike stable chronic disease, delaying or misjudging treatment can lead to myocardial damage and worse outcomes.
This “gray zone” requires thoughtful, patient-centered decision-making that balances symptoms, ischemic burden, viability, and procedural risk.
A recent review takes a deep dive into this evolving space, outlining how SCOs differ from both acute and chronic occlusions and why a tailored approach is essential for optimal care.
Read the full article here.
Understanding where a patient lies along the spectrum of coronary occlusion can make all the difference-especially when the path forward isn’t black and white.”
Article: Subacute coronary artery occlusion: complexities of the grey zone
Authors: Michaella Alexandrou, Yader Sandoval, Fernando Alfonso, Emmanouil S Brilakis
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH